Stay updated on ADT +/- Abiraterone/Prednisone + Apalutamide Clinical Trial
Sign up to get notified when there's something new on the ADT +/- Abiraterone/Prednisone + Apalutamide Clinical Trial page.

Latest updates to the ADT +/- Abiraterone/Prednisone + Apalutamide Clinical Trial page
- ChecktodayNo Change Detected
- Check8 days agoChange DetectedA new revision entry, v3.6.5, appears in the study record history, signaling an update to the page's metadata. The prior revision v3.6.4 was removed from the history view.SummaryDifference0.1%

- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedA new revision entry, v3.6.4, was added to the study's revision history and the previous v3.6.3 entry is removed from the visible history, reflecting an update to the record's versioning. This indicates an update to the study's revision metadata.SummaryDifference0.1%

- Check43 days agoChange DetectedThe history page now lists Revision: v3.6.3, replacing the previous v3.6.2. This indicates a platform release update rather than changes to study information.SummaryDifference0.1%

- Check50 days agoChange DetectedA new revision tag v3.6.2 is added to the study record history and the previous v3.6.0 tag is removed, reflecting a minor update to the page's versioning.SummaryDifference0.1%

- Check65 days agoChange DetectedRecruitment status updated to 'No longer looking for participants,' indicating accrual has ended for this study. The history now shows revision v3.6.0 as the current version, with v3.5.5 removed from the record history.SummaryDifference0.5%

- Check72 days agoChange DetectedThe Record History page now includes a new revision entry labeled v3.5.5, indicating an update to the page's revision history. The previous revision label v3.5.4 has been removed from the current change list, reflecting the latest version tracking for the study record.SummaryDifference0.1%

Stay in the know with updates to ADT +/- Abiraterone/Prednisone + Apalutamide Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ADT +/- Abiraterone/Prednisone + Apalutamide Clinical Trial page.